PHP
Parkman Healthcare Partners Portfolio holdings
AUM
$864M
This Quarter Return
+20.77%
1 Year Return
+33.7%
3 Year Return
+258.24%
5 Year Return
+878.92%
10 Year Return
–
AUM
$707M
AUM Growth
+$707M
(+30%)
Cap. Flow
+$87.9M
Cap. Flow
% of AUM
12.44%
Top 10 Holdings %
Top 10 Hldgs %
36.4%
Holding
113
New
10
Increased
54
Reduced
24
Closed
24
Top Buys
| 1 |
Abbott
ABT
|
$17.3M |
| 2 |
Inspire Medical Systems
INSP
|
$15.6M |
| 3 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$13.3M |
| 4 |
Amgen
AMGN
|
$12M |
| 5 |
Syndax Pharmaceuticals
SNDX
|
$11.4M |
Top Sells
| 1 |
HCA Healthcare
HCA
|
$13.8M |
| 2 |
IMGN
Immunogen Inc
IMGN
|
$11.4M |
| 3 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$8.68M |
| 4 |
Charles River Laboratories
CRL
|
$8.65M |
| 5 |
Zimmer Biomet
ZBH
|
$7.97M |
Sector Composition
| 1 | Healthcare | 99.16% |
| 2 | Industrials | 0.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMAM
76
DELISTED
Ambrx Biopharma, Inc. Common Stock
AMAM
| $1.25M | 0.18% |
87,678
-62,322
| -42% | -$887K |
|
77
Liquidia Corp
LQDA
$2.49B
| $1.22M | 0.17% |
101,767
-15,486
| -13% | -$186K |
|
78
Alpha Teknova
TKNO
$225M
| $1.05M | 0.15% |
282,236
+48,490
| +21% | +$181K |
|
79
SOPHiA GENETICS
SOPH
$230M
| $942K | 0.13% |
+199,997
| New | +$942K |
|
|
INZY
80
DELISTED
Inozyme Pharma
INZY
| $905K | 0.13% |
212,432
+36,536
| +21% | +$156K |
|
81
Eton Pharmaceutcials
ETON
$467M
| $872K | 0.12% |
199,168
+34,168
| +21% | +$150K |
|
82
Black Diamond Therapeutics
BDTX
$162M
| $713K | 0.1% |
253,717
-266,870
| -51% | -$750K |
|
83
TELA Bio
TELA
$65M
| $684K | 0.1% |
103,375
-63,350
| -38% | -$419K |
|
84
Tango Therapeutics
TNGX
$712M
| $650K | 0.09% |
65,679
-70,241
| -52% | -$695K |
|
85
X4 Pharmaceuticals
XFOR
$70.3M
| $643K | 0.09% |
767,332
-32,668
| -4% | -$27.4K |
|
86
Cogent Biosciences
COGT
$1.8B
| $569K | 0.08% |
96,837
-96,800
| -50% | -$569K |
|
87
Immunic
IMUX
$77.1M
| $153K | 0.02% |
102,256
-460,250
| -82% | -$690K |
|
|
ASLN
88
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
| $57.8K | 0.01% |
110,658
-262,083
| -70% | -$137K |
|
89
Aclaris Therapeutics
ACRS
$219M
| – | – |
-141,758
| Closed | -$971K |
|
90
Akero Therapeutics
AKRO
$3.61B
| – | – |
-116,107
| Closed | -$5.87M |
|
91
ANI Pharmaceuticals
ANIP
$2.03B
| – | – |
-111,802
| Closed | -$6.49M |
|
|
92
Charles River Laboratories
CRL
$7.94B
| – | – |
-44,160
| Closed | -$8.65M |
|
93
CRISPR Therapeutics
CRSP
$4.79B
| – | – |
0
| – | – |
|
94
Establishment Labs
ESTA
$1.11B
| – | – |
-60,530
| Closed | -$2.97M |
|
95
Evolent Health
EVH
$1.11B
| – | – |
-103,320
| Closed | -$2.81M |
|
96
Edwards Lifesciences
EW
$47.5B
| – | – |
-40,000
| Closed | -$2.77M |
|
|
97
HCA Healthcare
HCA
$95.3B
| – | – |
-56,160
| Closed | -$13.8M |
|
98
Lexicon Pharmaceuticals
LXRX
$396M
| – | – |
-1,136,413
| Closed | -$1.24M |
|
99
Mirum Pharmaceuticals
MIRM
$3.72B
| – | – |
-65,050
| Closed | -$2.06M |
|
100
Natera
NTRA
$22.8B
| – | – |
-50,751
| Closed | -$2.25M |
|